Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study
- PMID: 17199600
- DOI: 10.1111/j.1365-2133.2006.07595.x
Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study
Similar articles
-
Efficacy of topical tacrolimus in the treatment of various cutaneous manifestations of lupus erythematosus.Int J Dermatol. 2006 Jan;45(1):84-5. doi: 10.1111/j.1365-4632.2004.02539.x. Int J Dermatol. 2006. PMID: 16426386 No abstract available.
-
A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.Arch Dermatol. 2003 May;139(5):581-5. doi: 10.1001/archderm.139.5.581. Arch Dermatol. 2003. PMID: 12756094 Clinical Trial.
-
Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis.Eur J Dermatol. 2002 Jan-Feb;12(1):50-2. Eur J Dermatol. 2002. PMID: 11809595
-
The use of topical tacrolimus and pimecrolimus to treat psoriasis: a review.Dermatol Online J. 2004 Jul 15;10(1):3. Dermatol Online J. 2004. PMID: 15347485 Review.
-
Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation.Eur J Clin Pharmacol. 2008 Apr;64(4):337-41. doi: 10.1007/s00228-007-0421-2. Epub 2007 Dec 20. Eur J Clin Pharmacol. 2008. PMID: 18157526 Review.
Cited by
-
Pathogenesis and targeted treatment of skin injury in SLE.Nat Rev Rheumatol. 2015 Nov;11(11):663-9. doi: 10.1038/nrrheum.2015.106. Epub 2015 Aug 4. Nat Rev Rheumatol. 2015. PMID: 26241186 Review.
-
Interventions for cutaneous disease in systemic lupus erythematosus.Cochrane Database Syst Rev. 2021 Mar 9;3(3):CD007478. doi: 10.1002/14651858.CD007478.pub2. Cochrane Database Syst Rev. 2021. PMID: 33687069 Free PMC article.
-
Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria.J Clin Aesthet Dermatol. 2013 Jan;6(1):27-38. J Clin Aesthet Dermatol. 2013. PMID: 23320123 Free PMC article.
-
Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus.Arthritis Res Ther. 2012 Dec 7;14(6):R265. doi: 10.1186/ar4111. Arthritis Res Ther. 2012. PMID: 23217273 Free PMC article. Clinical Trial.
-
Cutaneous Lupus Erythematosus: Progress and Challenges.Curr Allergy Asthma Rep. 2020 Apr 4;20(5):12. doi: 10.1007/s11882-020-00906-8. Curr Allergy Asthma Rep. 2020. PMID: 32248318 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources